Efficacy and safety of novel twincretin tirzepatide, a dual GIP/GLP-1 receptor agonist, as an anti-obesity medicine in individuals without diabetes: a systematic review and meta-analysis
Why GLP-1 Medications Can Trigger Hair Loss Hair loss associated with GLP-1 medications is primarily a condition called telogen effluviuma temporary but distressing form of diffuse hair shedding triggered by metabolic stress
Patients should be especially cautious when a website sells products with language such as for research only, not for human use, laboratory use only, no prescription needed, retatrutide peptide for sale, or GLP-3 research peptide. These phrases are red flags when a person is considering using the product for themselves
Patients on GLP-1 drugs tend to have EWDR for one to two years after rapid A1c improvement
However, given the novelty of this therapeutic approach, the available evidence may be influenced by publication bias and early optimism, and long-term mechanistic and clinical outcome data remain limited
Maintain consistent skincare improvement takes time and patience